What does the HPLC area-percent table on a peptide COA actually report?
The headline purity figure on a peptide certificate of analysis is almost always a chromatographic area-percent, not a gravimetric mass fraction and not a net peptide content. In reversed-phase HPLC with ultraviolet or diode-array detection, the data system integrates detector response over time for each peak that meets the method’s integration rules, then expresses each peak’s area as a percentage of the sum of integrated peak areas. That sum is the calculation basis. Laboratories must read the footnote that defines the basis: “all peaks”, “all peaks above the reporting threshold”, or “all peaks excluding the solvent front and named counter-ion peaks”. Those three bases produce different headline numbers from the same raw trace. A 99.2% figure calculated after dropping the void and a trifluoroacetate peak is not comparable to a 97.8% figure calculated on all detected peaks without exclusion. Area-percent is a relative statement about the detector’s view of the solution at a stated wavelength (commonly 214 nm or 220 nm for peptides that lack a strong aromatic chromophore, or 280 nm when aromatic residues dominate). It is not a mass fraction, because molar absorptivity differs among the parent sequence and related substances. Net peptide content, water by Karl Fischer, and counter-ion content are separate fields. Australian laboratories should transcribe the calculation basis, wavelength, bandwidth and reporting threshold for each lot. Two lots cannot be ranked on the headline percentage alone if those parameters differ. A COA that prints only a single percentage without a peak list is a summary without evidence. Area normalisation cannot correct for non-eluting or non-absorbing components; an external-standard assay, if claimed, requires calibration documentation in the same packet.
How to read HPLC results on a peptide COA chromatogram PDF versus the area table
The chromatogram PDF is the primary experimental image; the area table is a derived reduction. Concordance checking confirms that both artefacts refer to the same run. Start with the PDF header: sample name, lot number, method identifier, instrument identifier, run date and time, detection wavelength, and user. Those fields should reappear on the COA. A mismatch in lot, method ID or date means the PDF is not evidence for the tabulated result. Read the time axis and integration window. The principal peak’s printed retention time should match the table within the method’s window. Peaks on the PDF but absent from the table usually reflect a reporting threshold, an ignore region, or a “do not report” event. Peaks in the table but faint on the PDF often reflect auto-scaling to the principal peak; an expanded-scale inset or a microvolt-second peak report resolves that. Structured reading of experimental material requires inspecting the figure and the numerical reduction together, as discussed in Suggestions on how to read experimental material in information science (1967). Advice in 13. How to read a journal article (1992) likewise asks what question the document answers and whether the displayed evidence supports the summary. Here the summary is the headline area-percent and the evidence is the integrated chromatogram. Importing a mass-purity meaning into an area-percent trace is a misreading of the kind warned against in How (Not) To Read Heidegger (1995). Confirm that any data-system peak table appended to the PDF matches the COA’s typeset table to the last reported decimal. Australian laboratories should file PDF and COA as one packet and treat unresolved mismatches as incomplete HPLC results.
Which HPLC method-identifier, column and mobile-phase fields must match the chromatogram header?
A chromatogram without a method identity is an untraceable picture. The COA should state a method code together with column chemistry, dimensions, particle size, mobile-phase A and B, gradient table or isocratic hold, flow rate, column temperature, sample diluent, sample introduction volume, and detection wavelength plus bandwidth. A C18 4.6 × 250 mm, 5 µm method is not interchangeable with a C18 2.1 × 50 mm, 1.7 µm method even if both are labelled “RP-HPLC purity”. The chromatogram header must reprint the same method code and critical parameters. If the COA says 220 nm and the PDF says 214 nm, the area-percent values are not results of the stated method. If the COA quotes a 30-minute gradient and the PDF axis ends at 15 minutes, the export may be cropped and late-eluting hydrophobic related substances may be invisible. Mobile-phase modifiers (trifluoroacetic acid versus formic acid) must be named; otherwise lots cannot be compared. Gradient tables should appear as time/composition pairs. Where relative retention time is used, the reference peak and the RRT formula must be stated, otherwise the RRT column is an unexplained number. Column temperature and flow rate underpin retention-time identity windows. Australian laboratories receiving local stock should copy these parameters into the lot file so a later repeat analysis can follow the original method rather than a generic C18 screen. Sample diluent and sample introduction volume belong in the same block because they affect the solvent-front size and the apparent recovery of hydrophobic sequences. These fields show that the purity chromatogram was acquired under a described method; they do not replace orthogonal identity documentation, which should be cross-referenced by lot number.
How are HPLC reporting thresholds, ignore limits and unidentified peaks shown on a peptide COA?
Reporting threshold is the area-percent or area-count below which peaks are omitted from the official table. It is not a limit of detection or a limit of quantification unless the COA says so. A 0.10% threshold means a 0.08% peak may appear on the PDF and not in the table. Summing tabulated related substances then underestimates detector-visible material. Specifying “report all peaks ≥0.05%” in purchasing documentation sets documentation granularity. Ignore regions exclude time windows, commonly the void and a modifier peak. If the ignore region is unstated, a polar deletion sequence may have been discarded as solvent. Unidentified peaks above the threshold should still be listed, typically as unknown, unidentified, or RRT only. Named related substances should use consistent identifiers across lots of the same catalogue item, with a stated naming basis (marker co-elution, RRT against a characterised impurity, or a separate LC–MS assignment). Reading tabulated numeric outputs requires an explicit account of the scoring rules, the point raised in HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? (2017). For HPLC those rules are the threshold, ignore region, integration algorithm (vertical drop, tangent skim, valley-to-valley), and whether area-percent is renormalised after exclusions. Changing a rule between lots changes the headline number without any change in the material. Australian research groups should record the rules in the lot file alongside the percentage and should not compare lots whose COAs omit them. Integration events printed on the PDF (start, stop, baseline type) should match the algorithm named on the COA. A valley-to-valley treatment of a poorly resolved pair will not give the same areas as a tangent skim. Shoulder peaks absorbed into the principal peak inflate apparent area-percent; that is visible only on the PDF.
What system-suitability and blank-run fields belong with HPLC results on Australian peptide COA documentation?
System suitability (SST) shows the chromatographic system was in a controlling state when the sample was run. Typical peptide RP-HPLC SST fields include retention-time and area repeatability, resolution of a critical pair, tailing factor or asymmetry, and theoretical plates or width at half height. Acceptance limits should be printed. A COA that states “system suitable” with no numbers is a conclusion without data. Blank or diluent chromatograms show whether peaks attributed to the sample arise from mobile phase, diluent or carry-over. A sample peak at the same retention time and comparable area as a blank peak should not be classified as a related substance. Australian laboratories should expect a blank trace or a statement that the blank was free of peaks above the reporting threshold in the integration window. The sequence should show blank, SST, sample, and a closing SST so drift can be assessed. If SST claims Rs ≥ 2.0, the PDF should show two baseline-resolved peaks at the stated times. A tailing factor near 1.8 on the principal peak indicates that a close-eluting related substance could sit in the tail and inflate principal-peak area-percent. Finding the SST record is part of using a documentation system, as illustrated in Documentation about Atlas of Living Australia tools: how to find information (2017), which concerns locating supporting records rather than relying on a summary banner. The summarised cover percentage is not the underlying record, a distinction also familiar from Review: The Business of Books: How International Conglomerates Took over Publishing and Changed the Way We Read (2002). Tracked dispatch and local Australian stock establish custody of the vial; they do not replace SST in the HPLC packet.
How do lot, vial and batch identifiers link HPLC results to material received in Australia?
An HPLC result that cannot be tied to the vial on the bench is not a result for that vial. The COA lot number must match the vial label, the chromatogram PDF, and any mass-spectrometric identity report. If vial labels and the COA disagree on lot number, the HPLC results do not describe the received material and the packet should be held until identifiers are reconciled. Multi-vial orders from one lot share one HPLC packet; the documentation should say so. Catalogue codes should match the identity claimed in the packet. Nominal milligram content on the label is a labelling field, not an HPLC result. Australian procurement practice uses local stock and tracked dispatch so custody from warehouse release to laboratory receipt can be filed beside the batch packet without substituting for it. Record dispatch identifier, received date and lot number together. Mixing custody fields with purity fields makes later trend review impossible. If a supplier issues a revised COA for the same lot, retain both versions and mark the superseded copy. Silent replacement of PDFs without revision history breaks the audit trail. Documentation systems succeed when users can find the matching record, the practical concern of Documentation about Atlas of Living Australia tools: how to find information (2017). Misreading occurs when a document is asked to answer a question it does not address, the caution in How (Not) To Read Heidegger (1995). Retention time is not a sequence. Area-percent is not net content. A matching lot number is not a substitute for either. Each field answers one question and should remain separable in the Australian laboratory file.
Apply this checklist to documented stock
You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.
Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.
Frequently asked questions
Does a high HPLC area-percent on a peptide COA make the chromatogram PDF optional?
No. Area-percent is a reduction of the chromatogram under stated rules. Without the PDF, a laboratory cannot see ignored regions, shoulders, y-axis scaling or peaks below the reporting threshold. Australian research files should keep both artefacts under the same lot identifier. Research-use documentation only.
What should an Australian laboratory do if the peptide COA table and the HPLC chromatogram PDF disagree?
Treat the packet as incomplete. Check lot number, method ID, date, wavelength and principal-peak retention time first. If identifiers match but peak lists do not, the reporting threshold, ignore region or transcription may differ. Do not average the two percentages. Hold the file until a concordant revision is issued.
Can retention time on a peptide COA replace mass-spectrometric identity?
No. Retention time is a method-dependent marker. It supports identity only within a stated window under named column, modifier, temperature and flow. Sequence confirmation requires orthogonal mass data filed under the same lot. Reading HPLC results does not convert a purity chromatogram into an identity assay.
Which fields on Australian peptide COA documentation are custody fields rather than HPLC results?
Dispatch identifiers, received date, warehouse-release notes and vial counts are custody fields. Lot numbers link custody to HPLC but are not chromatographic data. Nominal label mass is a labelling field. Mixing these with area-percent in one undifferentiated spreadsheet undermines later review.
How should two suppliers’ HPLC reporting thresholds be compared in Australia?
Copy each threshold, ignore region, calculation basis and wavelength into the comparison table before ranking headline percentages. A 99.4% result at a 0.10% threshold is not the same documentary claim as a 99.1% result that lists all peaks at or above 0.05%. Compare rules, then numbers.
Is local Australian stock a substitute for system-suitability data on the COA?
No. Local stock and tracked dispatch document custody of the vial. System-suitability numbers document that the HPLC system met its checks when the chromatogram was acquired. Both belong in the lot file; neither replaces the other. Research-use laboratory documentation only.
References
- DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
- DOI:10.5694/j.1326-5377.1992.tb137249.x — 13. How to read a journal article — Medical Journal of Australia — 1992
- DOI:10.5840/acpq199569241 — How (Not) To Read Heidegger — American Catholic Philosophical Quarterly — 1995
- DOI:10.3897/tdwgproceedings.1.19941 — Documentation about Atlas of Living Australia tools: how to find information — Proceedings of TDWG — 2017
- DOI:10.7816/ulakbilge-05-15-06 — HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? — Ulakbilge Dergisi — 2017
- DOI:10.1177/1329878x0210300127 — Review: The Business of Books: How International Conglomerates Took over Publishing and Changed the Way We Read — Media International Australia — 2002
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
